Developing new vaccine adjuvants to improve immune responses
VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES
This study is looking at a new way to make flu vaccines work better by using a special ingredient that helps boost your immune system, which could lead to stronger protection against the flu for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10935774 on NIH RePORTER |
What this research studies
This research focuses on enhancing vaccine effectiveness by developing novel adjuvants that activate the immune system. By using high throughput screening techniques on human cells, researchers have identified a promising compound that stimulates immune responses through specific receptors. The project aims to optimize this adjuvant in combination with existing influenza vaccines to improve their ability to protect against infections. Patients may benefit from improved vaccine responses, leading to better protection against diseases like influenza.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at risk for influenza and may benefit from enhanced vaccine responses.
Not a fit: Patients who are not at risk for influenza or who have contraindications to vaccination may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that provide stronger and longer-lasting protection against infectious diseases.
How similar studies have performed: Previous research has shown success in using adjuvants to enhance vaccine responses, making this approach promising and not entirely novel.
Where this research is happening
Boston, United States
- Boston Children's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Heilherker, Tyson — Boston Children's Hospital
- Study coordinator: Heilherker, Tyson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.